Uncover key drivers, emerging technologies, and competitive movements shaping the digital rights management software market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Porcine Vaccine Market reach by 2030 starting from 2026 levels?

The porcine vaccine market has seen robust growth in recent years. It is anticipated to increase from $2.05 billion in 2025 to $2.25 billion in 2026, registering a compound annual growth rate (CAGR) of 9.4%. Historically, this market expansion has been driven by outbreaks of swine diseases, rising pork consumption, the development of traditional vaccines, increasing veterinary awareness, and the expansion of hog farming infrastructure.

The porcine vaccine market is projected for significant expansion over the coming years, reaching a valuation of $3.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth throughout the forecast period stems from factors such as the proliferation of recombinant and DNA vaccines, the embrace of precision veterinary medicine, a heightened emphasis on herd immunity initiatives, continuous technological improvements in vaccine delivery methods, and escalating government efforts for animal health. Key developments anticipated during this period encompass the use of multi-strain vaccines for pigs, a stronger commitment to disease prevention within swine herds, increased financial commitments to swine immunization programs, the incorporation of veterinary advisory services into farm operations, and the broadening of cold chain infrastructure for vaccine dissemination.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp

Which Drivers Are Influencing Long-Term Growth In The Porcine Vaccine Market?

Growing pork consumption is projected to stimulate the expansion of the porcine vaccine market. Pork consumption denotes the quantity of pork meat consumed by individuals or groups within a specified timeframe. This consumption has increased in line with the growing global population and the rising demand for protein. The porcine vaccine market supports higher pork consumption by helping to prevent diseases in pigs, improve herd health, and ensure a stable supply of safe and high-quality pork products. For instance, in July 2024, according to INAPORC (Interprofession Nationale Porcine), a France-based national pork association, pork remained the most consumed meat in France in 2023, with approximately 30.6 kg per person per year. Thus, the escalating consumption of pork is driving the growth of the porcine vaccine market.

How Is The Porcine Vaccine Market Divided Into Segments?

The porcine vaccine market covered in this report is segmented –

1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines

2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications

3) By End User: Veterinary Hospitals, Hog Or Pig Production Farm

Subsegments:

1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines

2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines

3) By Toxoid Vaccines: Inactivated Toxins

4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines

5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines

6) By DNA Vaccines: Plasmid DNA Vaccines

What Trends Are Driving The Growth Trajectory Of The Porcine Vaccine Market?

Key companies operating within the porcine vaccine sector are establishing strategic alliances to advance their research and development proficiencies and reinforce their competitive standing in the dynamic animal health industry. These collaborations leverage The Vaccine Group’s expertise in vaccine technology and The Pirbright Institute’s specialized knowledge in African swine fever (ASF) research. The aim of this partnership is to optimize the vaccine development process and devise innovative approaches that could significantly improve swine health. For example, in May 2024, The Pirbright Institute, a UK-based research institute, collaborated with The Vaccine Group (TVG), a UK-based company, to create a vaccine for African swine fever (ASF). The research intends to produce vaccines to prevent African swine fever (ASF) by employing bovine herpesvirus 4 (BoHV-4) as its fundamental basis. This strategy incorporates the latest advancements in ASF vaccine investigation and pig immunology to engineer more effective vaccines. The initiative is supported financially by the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).

Which Major Industry Participants Are Leading The Porcine Vaccine Market Growth?

Major companies operating in the porcine vaccine market are Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., IDT Biologika GmbH, Biogénesis Bagó, Aptimmune Biologics Inc., Virbac S.A., Vaxxinova International BV, Bioveta a.s., Indian Immunologicals Limited, KM Biologics, Addison Biological Laboratory, Colorado Serum Company, CAHIC China Animal Husbandry Industry Co, Tecon, Hile Bio, WINSUN

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Porcine Vaccine Market?

North America is the largest region in the porcine vaccine market in 2025. The regions covered in the porcine vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Porcine Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9111&type=smp

Browse Through More Reports Similar to the Global Porcine Vaccine Market 2026, By The Business Research Company

Porcine Epidemic Diarrhea Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Swine Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company